Skip to main content
PMC home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2007 Nov 14;30(11):567–575. doi: 10.1002/clc.20250

Reducing Events in Patients with Chronic Heart Failure (REDUCEhf ) Study Design: Continuous Hemodynamic Monitoring with an Implantable Defibrillator

Philip B Adamson MD 1,✉, Jamie B Conti MD 2, Andrew L Smith MD 3, William T Abraham MD 4, Mark F Aaron MD 5, Juan M Aranda, Jr MD 2, James Baker MD 5, Robert C Bourge MD 6, Lynne Warner‐Stevenson MD 7, Brandon Sparks MS 8
PMCID: PMC6653489  PMID: 18000962

Abstract

Background

The use of implantable cardioverter defibrillators (ICDs) has been proven effective in the prevention of sudden cardiac death (SCD) and constitutes standard of care in appropriate populations. Combining a pressure sensing system with ICD therapy represents the first attempt to provide continuous hemodynamic monitoring using a device previously designed exclusively for SCD protection.

Methods

REDUCE is a prospective, multicenter, randomized, single‐blind, parallel‐controlled trial designed to assess the safety of the Chronicle ICD system (single chamber ICD with a hemodynamic monitoring system) and the effectiveness of a management strategy guided by intracardiac pressure information among ICD‐indicated New York Heart Association (NYHA) Class II or III heart failure (HF) patients. Those successfully implanted with a Chronicle ICD will be randomized to the Chronicle group or Control group. All patients will receive optimal medical therapy, but the hemodynamic information from the device will be used to guide patient management only in the Chronicle group. Primary endpoints include freedom from system‐related complications and relative risk reduction of one or more HF‐related events (hospitalizations, and emergency department and urgent care visits requiring intravenous therapy for HF). Approximately 850 patients will be enrolled in at least 75 centers in the United States to accrue the 419 events needed to test the primary effectiveness endpoint. Enrollment began in April 2006, and is expected to end during 2009.

Conclusion

REDUCE will assess the safety of the Chronicle ICD system and the effectiveness of a patient management strategy based on remote access to continuous intracardiac pressures in reducing HF‐related events. Copyright © 2007 Wiley Periodicals, Inc.

Keywords: heart failure, disease management, ambulatory monitoring, hemodynamics, hospitalization, implantable cardioverter defibrillators

Full Text

The Full Text of this article is available as a PDF (693.0 KB).

References

  • 1. Adams KF, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, et al.: Characteristics and outcomes of patients hospitalized for heart failure in the United States. Rationale, design and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure Registry (ADHERE). Am Heart J 2005; 149(2): 209–216. [DOI] [PubMed] [Google Scholar]
  • 2. Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, et al.: Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA 2007; 297(1): 61–70. [DOI] [PubMed] [Google Scholar]
  • 3. Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, et al.: Systolic blood pressure at admission, clinical characteristics and outcomes in patients hospitalized with acute heart failure. JAMA 2006; 296(18): 2217–2226. [DOI] [PubMed] [Google Scholar]
  • 4. Fonarow GC: The Acute Decompensated Heart Failure National Registry (ADHERE): Opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med 2003; 4(suppl 7): S21–S30. [PubMed] [Google Scholar]
  • 5. Stevenson LW, Perloff JK: The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 1989; 261(6): 884–888. [PubMed] [Google Scholar]
  • 6. Capomolla S, Ceresa M, Pinna G, Maestri R, La Rovere MT, et al.: Echo‐Doppler and clinical evaluations to define hemodynamic profile in patients with chronic heart failure: accuracy and influence on therapeutic management. Eur J Heart Fail 2005; 7(4): 624–630. [DOI] [PubMed] [Google Scholar]
  • 7. Goldberg LR, Piette JD, Walsh MN, Frank TA, Jaski BE, et al.: Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial. Am Heart J 2003; 146(4): 705–712. [DOI] [PubMed] [Google Scholar]
  • 8. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, et al.: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Mulicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335(26): 1933–1940. [DOI] [PubMed] [Google Scholar]
  • 9. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, et al.: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346(12): 877–883. [DOI] [PubMed] [Google Scholar]
  • 10. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, et al.: Amiodarone or an implantable cardioverter‐defibrillator for congestive heart failure. N Engl J Med 2005; 352(3): 225–237. [DOI] [PubMed] [Google Scholar]
  • 11. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, et al.: Cardiac‐resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350(21): 2140–2150. [DOI] [PubMed] [Google Scholar]
  • 12. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, et al.: ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). American College of Cardiology 2005; 112(12): 1825–1852, Web Site Available at: http://content.onlinejacc.org/cgi/ Circulation. [DOI] [PubMed] [Google Scholar]
  • 13. Adamson PB, Vanoli E. Prevention of sudden death in heart failure In Congestive Heart Failure (3rd ed.) (Eds.Hosenpud JD, Greenberg BH.), pp. 697–710. Philadelphia, PA: Lippincott Williams and Wilkins, 2007. [Google Scholar]
  • 14. Adamson PB, Gilbert EM: Reducing risk of sudden cardiac death in heart failure with beta blockers. J Card Fail 2006; 12(9): 734–736. [DOI] [PubMed] [Google Scholar]
  • 15. Yu CM, Wang L, Chau E, Chan RH, Kong SL, et al.: Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 2005; 112(6): 841–848. [DOI] [PubMed] [Google Scholar]
  • 16. Adamson PB, Kleckner KJ, Van Hout WL, Srinivasan S, Abraham WT, et al.: Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure. Circulation 2003; 108(3): 266–269. [DOI] [PubMed] [Google Scholar]
  • 17. Adamson PB, Smith AL, Abraham WT, Kleckner KJ, Stadler RW, et al.: Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation 2004; 110(16): 2389–2394. [DOI] [PubMed] [Google Scholar]
  • 18. Adamson PB: Continuous heart rate variability from an implanted device: a practical guide for clinical use. Congest Heart Fail 2005; 11: 327–336. [DOI] [PubMed] [Google Scholar]
  • 19. Magalski A, Adamson P, Gadler F, Böehm M, Steinhaus D, et al.: Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: a multicenter, 12‐month follow‐up study of patients with chronic heart failure. J Card Fail 2002; 8(2): 63–70. [DOI] [PubMed] [Google Scholar]
  • 20. Adamson PB, Kjellstrom B, Braunschweig F, Magalski A, Linde C, et al.: Ambulatory hemodynamic monitoring from an implanted device: components of continuous 24‐hour pressures that correlate to supine resting conditions and acute right heart catheterization. Congest Heart Fail 2006; 12(1): 14–19. [DOI] [PubMed] [Google Scholar]
  • 21. Adamson PB, Magalski A, Braunschweig F, Böhm M, Reynolds D, et al.: Ongoing right ventricular hemodynamics in heart failure: Clinical value of measurement derived from an implantable monitoring system. J Am Coll Cardiol 2003; 41(4): 563–567. [DOI] [PubMed] [Google Scholar]
  • 22. Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM Jr, et al.: Randomized controlled trial of an implantable hemodynamic monitor in advanced heart failure: The Chronicle Implantable Hemodynamic Monitor offers management to patients with advanced signs and symptoms of heart failure (COMPASS‐HF) study. J Am Coll Cardiol, Submitted to. [DOI] [PubMed] [Google Scholar]
  • 23. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al.: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130(6): 461–470. [DOI] [PubMed] [Google Scholar]
  • 24. Packer M: Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. J Card Fail 2001; 7: 176–82. [DOI] [PubMed] [Google Scholar]
  • 25. Reynolds DW, Bartelt N, Taepke R, Bennett TD: Measurement of pulmonary artery diastolic pressure from the right ventricle. J Am Coll Cardiol 1995; 25(5): 1176–1182. [DOI] [PubMed] [Google Scholar]
  • 26. Braunschweig F, Linde C, Eriksson MJ, Hofman‐Bang C, Rydén L: Continuous hemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure. Eur Heart J 2002; 23(1): 59–69. [DOI] [PubMed] [Google Scholar]
  • 27. Ohlsson A, Bennett T, Nordlander R, Rydén J, Aström H, et al.: Monitoring of pulmonary arterial diastolic pressure through a right ventricular pressure transducer. J Card Fail 1995; 1(2): 161–168. [DOI] [PubMed] [Google Scholar]
  • 28. Chuang PP, Wilson RF, Homans DC, Stone K, Bergman T, et al.: Measurement of pulmonary artery diastolic pressure from a right ventricular pressure transducer in patients with heart failure. J Card Fail 1996; 2(1): 41–46. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES